Table 3 Risk factors and comorbidity of individuals with serrated polyps according to Swedish histopathology reports
From: Validation of serrated polyps (SPs) in Swedish pathology registers
Variable | HP | TSA | SSA/P | U | F | Total | |||
|---|---|---|---|---|---|---|---|---|---|
SSA/P | SA | Mixed | Total | ||||||
INDIVIDUALS | 34 (32%) | 3 (3%) | 8 (8%) | 51 (48%) | 12 (11%) | 70 (66%) | 3 (3%) | 5 (5%) | 106 (100%) |
Smoking | |||||||||
 Current | 8 (24%) | 1 (33%) | 1 (13%) | 2 (4%) | 4 (33%) | 7 (10%) | 2 (67%) | 0 (0%) | 16 (15%) |
 Previous | 5 (15%) | 2 (67%) | 3 (38%) | 5 (10%) | 2 (17%) | 10 (14%) | 0 (0%) | 0 (0%) | 14 (13%) |
BMI | |||||||||
 Obese* | 3 (9%) | 2 (67%) | 2 (25%) | 5 (10%) | 1 (8%) | 8 (11%) | 1 (33%) | 0 (0%) | 12 (11%) |
Heredity | |||||||||
 CRC + § | 2 (6%) | 0 (0%) | 2 (25%) | 1 (2%) | 1 (8%) | 4 (6%) | 1 (33%) | 0 (0%) | 7 (7%) |
Comorbidity | |||||||||
 Diverticulosis | 9 (26%) | 1 (33%) | 4 (50%) | 24 (47%) | 8 (67%) | 36 (51%) | 1 (33%) | 1 (20%) | 45 (42%) |
 CRC | 3 (9%) | 1 (33%) | 3 (38%) | 10 (20%) | 3 (25%) | 15 (21%) | 2 (67%) | 0 (0% | 19 (18%) |
 IBD | 4 (12%) | 0 (0%) | 0 (0%) | 5 (10%) | 1 (8%) | 6 (9%) | 0 (0%) | 0 (0%) | 10 (9%) |